Clinical progression of baseline risk states for mild cognitive impairment

Manuscript Number: 

21-5607R2

Author(s): 
Sarah B. Berman, Meryl A. Butters, Yu Cheng, Sarah M. Goldberg, Swathi Gujral, Oscar Lopez, Beth E. Snitz, Robert A. Sweet, Andrea Weinstein, Yanji Zhao

Disclosures

Sarah B. Berman

  • Nothing to Disclose

Meryl A. Butters

  • Nothing to Disclose

Yu Cheng

  • Nothing to Disclose

Sarah M. Goldberg

  • Nothing to Disclose

Swathi Gujral

  • Nothing to Disclose

Oscar Lopez

  • Consulting Fees:
    Consultant for Grifols, Biogen, and Eisai.

Beth E. Snitz

  • Consulting Fees:
    Advisory board for NIH grant: Eschman CAMCI (SB1 AG037357-04A1) $1,000 per year of service

Robert A. Sweet

  • Nothing to Disclose

Andrea Weinstein

  • Nothing to Disclose

Yanji Zhao

  • Nothing to Disclose